Chemical Compound
3,5-Pyrazolidinedione, 1,2-diphenyl-4-[2-(phenylsulfinyl)ethyl]-; 1,2-Diphenyl-4-(2'-phenylsulfinethyl)-3,5-pyrazolidinedione; 1,2-Diphenyl-4-[2-(phenylsulfinyl)ethyl]-3,5-pyrazolidinedione; 4-(Phenylsulfoxyethyl)-1,2-diphenyl-3,5-pyrazolidinedione; Anturan; Anturane; Anturanil; Anturen; Anturidin; Diphenylpyrazone; Enturan; Enturen; G 28315; NSC 75925; Sulfinpyrazon; Sulfinpyrazone; Sulfoxyphenylpyrazolidine; Sulphinpyrazone
CAS Registry Number
57-96-5
Primary record
3,5-Pyrazolidinedione, 1,2-diphenyl-4-[2-(phenylsulfinyl)ethyl]-; 1,2-Diphenyl-4-(2'-phenylsulfinethyl)-3,5-pyrazolidinedione; 1,2-Diphenyl-4-[2-(phenylsulfinyl)ethyl]-3,5-pyrazolidinedione; 4-(Phenylsulfoxyethyl)-1,2-diphenyl-3,5-pyrazolidinedione; Anturan; Anturane; Anturanil; Anturen; Anturidin; Diphenylpyrazone; Enturan; Enturen; G 28315; NSC 75925; Sulfinpyrazon; Sulfinpyrazone; Sulfoxyphenylpyrazolidine; Sulphinpyrazone
- 库存
- 4,350 克
- 纯度
- 98.3 %
- CAS
- 57-96-5
化合物标识与属性
- CAS
- 57-96-5
- PubChem CID
- 5342
- SMILES
- C1=CC=C(C=C1)N2C(=O)C(C(=O)N2C3=CC=CC=C3)CCS(=O)C4=CC=CC=C4
- Canonical SMILES
- O=C1C(CCS(=O)c2ccccc2)C(=O)N(c2ccccc2)N1c1ccccc1
名称与同义词
- sulfinpyrazone
- Sulphinpyrazone
- Anturane
- Anturan
- Diphenylpyrazone
- Sulfinpyrazon
- Anturidin
- Enturen
- Anturanil
- Anturano
- Sulfoxyphenylpyrazolidine
- Sulfinpirazona
- Sulfinpyrazine
- Sulfinpyrazonum
- 57-96-5
- (+/-)-SULFINPYRAZONE
- Anturen
- Enturan
- Apo-Sulfinpyrazone
- Novopyrazone
- Nu Sulfinpyrazone
- USAF GE-13
- Apo Sulfinpyrazone
- sufinpyrazone
- sulfinpirazone
- suphinpyrazone
- Sulfoxyphenylpyrazolidin
- Anturane (TN)
- Nu-Sulfinpyrazone
- sulfinpyrazon-
- Sulphinepyrazolone
- (?-Sulfinpyrazone
- Sulfinpyrazone CRS
- sulfinpyrazone (SPZ)
- Prestwick_455
- Sulfinpyrazonum [INN-Latin]
- (-+)-sulfinpyrazone
- Sulfinpirazona [INN-Spanish]
- ( )-Sulfinpyrazone
- 1,5-pyrazolidinedione
- 1,2-Diphenyl-4-(2-(phenylsulfinyl)ethyl)pyrazolidine-3,5-dione
- C23H20N2O3S
- V6OFU47K3W
- NSC 75925
- Spectrum_001022
- A1EAY
- RefChem:57631
- UNII-V6OFU47K3W
- DTXSID0023618
- Diphenylpyrazone;G-28315
- Prestwick0_000290
- Prestwick1_000290
- Prestwick2_000290
- Prestwick3_000290
- Spectrum2_001324
- Spectrum3_000590
- Spectrum4_000845
- Spectrum5_000984
- CHEBI:9342
- Sulfinpyrazone (Standard)
- MBGGBVCUIVRRBF-UHFFFAOYSA-N
- CHEMBL832
- D03DEI
- HSDB 3396
- SULFINPYRAZONE [MI]
- Sulfinpyrazone [USAN:INN:JAN]
- AC1L1K4Z
- DTXCID003618
- SULFINPYRAZONE [INN]
- SULFINPYRAZONE [JAN]
- BIDD:PXR0096
- MFCD00057279
- NSC-75925
- SCHEMBL34421
- BSPBio_000200
- BSPBio_002040
- KBioGR_001449
- KBioSS_001502
- 4-[2-(benzenesulfinyl)ethyl]-1,2-diphenylpyrazolidine-3,5-dione
- MLS000028565
- MLS001074941
- NSC75925
- DivK1c_000090
- SPECTRUM1500554
- SULFINPYRAZONE [VANDF]
- Apotex Brand of Sulfinpyrazone
- EINECS 200-357-4
- SPBio_001447
- SPBio_002419
- SULFINPYRAZONE [MART.]
- BPBio1_000220
- GTPL5826
- orb1310619
- G 28315
- Sulfinpyrazone (JAN/USP/INN)
- SULFINPYRAZONE [USP-RS]
- SULFINPYRAZONE [WHO-DD]
- Novartis Brand of Sulfinpyrazone
- CTK8F1547
- ERK5-2K11
- HMS500E12
- HY-B1271R
- KBio1_000090
- KBio2_001502
- KBio2_004070
- KBio2_006638
- KBio3_001540
- Nu Pharm Brand of Sulfinpyrazone
- Nu-Pharm Brand of Sulfinpyrazone
- BRN 0713597
- CID5342
- M04AB02
- Sulfinpyrazone [USP:INN:BAN:JAN]
- 4-dodecanoylpiperazine-2,6-dione
- NINDS_000090
- Sulfinpyrazone (JP15/USP/INN)
- HMS1568J22
- HMS1921C09
- HMS2092K11
- HMS2095J22
- HMS2233H11
- HMS3259I06
- HMS3371B22
- HMS3712J22
- HMS3885F12
- HMS5083I04
- Pharmakon1600-01500554
- 4-(Phenylsulfoxyethyl)-1,2-diphenyl-3,5-pyrazolidinedione
- ACN-S002471
- BCP05344
- CID:5342
- HY-B1271
- KS-00000L9C
- MSK10112
- 1,2-Diphenyl-4-(2'-phenylsulfinethyl)-3,5-pyrazolidinedione
- CAS-57-96-5
- G-28315
- SULFINPYRAZONE [EP IMPURITY]
- SULFINPYRAZONE [ORANGE BOOK]
- Sulfinpyrazone for system suitability
- Tox21_110331
- 8566AB
- BDBM50237626
- C23-H20-N2-O3-S
- CCG-39262
- EBC-08962
- G 28,315
- NCGC00016255-01
- NSC757332
- s4628
- SBB058184
- SULFINPYRAZONE [EP MONOGRAPH]
- SULFINPYRAZONE [USP IMPURITY]
- 1,2-Diphenyl-3,5-dioxo-4-(2-phenylsulfinylethyl)pyrazolidine
- AKOS015913283
- Tox21_110331_1
- 4-(2-Benzenesulfinylethyl)-1,2-diphenylpyrazolidine-3,5-dione
- DB01138
- DS-6609
- J1.384F
- NC00539
- NSC-757332
- TRA0061733
- 3,5-Pyrazolidinedione, 1,2-diphenyl-4-(2-(phenylsulfinyl)ethyl)-
- IDI1_000090
- ( inverted exclamation markA)-Sulfinpyrazone
- (invertedexclamationmarkA)-Sulfinpyrazone
- NCGC00016255-02
- NCGC00016255-03
- NCGC00016255-04
- NCGC00016255-05
- NCGC00016255-06
- NCGC00016255-07
- NCGC00016255-10
- NCGC00018267-01
- NCGC00023932-03
- NCGC00023932-04
- AC-13602
- AC-32767
- AK122319
- AN-23594
- BC206492
- CPD000058991
- SAM002554932
- SID:53789714
- SMR000058991
- Sulfinpyrazone for system suitability CRS
- (+/-)-Sulfinpyrazone, analytical standard
- SBI-0051528.P003
- WLN: T5VNNV EHJ BR& CR& E2SO&R
- 1,2-Diphenyl-4-[2-(phenylsulfinyl)ethyl]-3,5-pyrazolidinedione
- DB-053135
- LS-128688
- ( inverted exclamation mark_)-Sulfinpyrazone
- 3,5-Pyrazolidinedione, 1,2-diphenyl-4-[2-(phenylsulfinyl)ethyl]-
- AB00052103
- CS-0013052
- NS00004052
- ST51015125
- U0114
- 4-(Phenylsulfoxyethyl)-1,5-pyrazolidinedione
- 5-25-02-00397 (Beilstein Handbook Reference)
- 1,2-Diphenyl-4-(2-(phenylsulfinyl)ethyl)-3,5-pyrazolidinedione
- C07317
- D00449
- EN300-124005
- H10364
- 1,2-Diphenyl-3,5-dioxo-4-(2'-phenyl-sulfinyl-aethyl)-pyrazolidin
- 3, 1,2-diphenyl-4-[2-(phenylsulfinyl)ethyl]-
- 32301-EP2281815A1
- 32301-EP2301933A1
- 32301-EP2305640A2
- 32301-EP2311827A1
- AB00052103_13
- 1,2-Diphenyl-4-[2-(phenylsulfinyl)ethyl-3,5-pyrazolidinedione
- A869550
- D013442
- SR-01000003152
- 1,2-Diphenyl-3,5-dioxo-4-(2'-phenyl-sulfinyl-aethyl)-pyrazolidin [German]
- 1,2-diphenyl-4-[2-(phenylsulfinyl)ethyl]pyrazolidine-3,5-dione
- 4-[2-(benzenesulfinyl)ethyl]-1,2-diphenyl-pyrazolidine-3,5-dione
- Q3790542
- SR-01000003152-2
- SR-01000003152-4
- 1,2-Diphenyl-4-(phenylsulfinylethyl)-3,5-pyrazolidinedione
- BRD-A36217750-001-05-6
- BRD-A36217750-001-09-8
- BRD-A36217750-001-16-3
- I14-45370
- 1,2-Diphenyl-3,5-dioxo-4-(2-phenylsulfinylethyl) pyrazolidine
- Z1557407327
- 1,2-diphenyl-4-(2-phenylsulfinylethyl)pyrazolidine-3,5-dione
- Sulfinpyrazone, European Pharmacopoeia (EP) Reference Standard
- 1,2-di(phenyl)-4-(2-phenylsulfinylethyl)pyrazolidine-3,5-dione
- 1,2-Diphenyl-3,5-dioxo- 4- (2-phenylsulfinylethyl) pyrazolidine
- 1,2-diphenyl-4-[2-(phenylsulfinyl)-ethyl]-pyrazolidine-3,5-dione
- 1,2-Diphenyl-4beta-[2-(phenylsulfinyl)ethyl]-3,5-pyrazolidinedione
- 4-(2-(benzenesulfinyl)ethyl)-1,2-diphenylpyrazolidine-3,5-dione
- Sulfinpyrazone, United States Pharmacopeia (USP) Reference Standard
- (4alpha)-1,2-Diphenyl-4-[2-(phenylsulfinyl)ethyl]-3,5-pyrazolidinedione
- (4beta)-1,2-Diphenyl-4-[2-(phenylsulfinyl)ethyl]-3,5-pyrazolidinedione
- 1,2-diphenyl-4-[2-(phenylsulfinyl)ethyl]-1,2-diazolidine-3,5-dione
- 1,2-Diphenyl-4alpha-[2-(phenylsulfinyl)ethyl]-3,5-pyrazolidinedione
- Sulfinpyrazone for system suitability, European Pharmacopoeia (EP) Reference Standard
- 200-357-4
- 3,5-Pyrazolidinedione, 1,2-diphenyl-4-[2-(phenylsulfinyl)ethyl]-; 1,2-Diphenyl-4-(2'-phenylsulfinethyl)-3,5-pyrazolidinedione; 1,2-Diphenyl-4-[2-(phenylsulfinyl)ethyl]-3,5-pyrazolidinedione; 4-(Phenylsulfoxyethyl)-1,2-diphenyl-3,5-pyrazolidinedione; Anturan; Anturane; Anturanil; Anturen; Anturidin; Diphenylpyrazone; Enturan; Enturen; G 28315; NSC 75925; Sulfinpyrazon; Sulfinpyrazone; Sulfoxyphenylpyrazolidine; Sulphinpyrazone